DiaMedica Therapeutics has seen its Relative Strength Index (RSI) drop to 28.4, signaling potential exhaustion in recent selling pressure. Technical indicators suggest the stock may be approaching a bottom as it trades near the lower end of its yearly range.
- RSI reading of 28.4 indicates oversold conditions
- Intraday low reached $6.065 per share
- Last trade recorded at $6.19
- 52-week range spans from $3.26 to $10.4195
- Broad market (SPY) remains stronger with an RSI of 57.1
Sign up free to read the full analysis
Create a free account to unlock full AI-curated market articles, personalized alerts, and more.